Improved antiretroviral refill adherence in HIV-focused community pharmacies

Journal of the American Pharmacists Association

Volumn 52, Issue 5, 2012, Pages

  Cocohoba, Jennifer M ^a   Murphy, Patricia ^b   Pietrandoni, Glen ^c   Guglielmo, B Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Clinical Outcomes and Analytics   (United States)

^c Pharmacy Service (119)   (United States)

Author keywords

Antiretroviral agents; Community pharmacy; Human immunodeficiency virus; Medication adherence; Medication therapy management

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; BILLING AND CLAIMS; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENDER; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV FOCUSED PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICATION COMPLIANCE; MODIFIED MEDICATION POSSESSION RATIO; PATIENT COMPLIANCE; PATIENT REFERRAL; PHARMACY; PRESCRIPTION; TABLET FORMULATION; TRADITIONAL PHARMACY; COMORBIDITY; DRUG COMBINATION; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; CALIFORNIA; COMMUNITY PHARMACY SERVICES; COMORBIDITY; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDIES;

EID: 84874447659     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.11112     Document Type: Article

References (37)

1. Press N, Tyndall MW, Wood E, et al. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S112-7.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
3. Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36:514-8.
4. Jodlowski TZ, Sym D, Conry J, et al. Antiretroviral medication knowledge among New York State pharmacists: room for improvement. J Pharm Pract. 2010;23:507-10.
5. Racey CS, Zhang W, Brandson EK, et al. HIV antiviral drug resistance: patient comprehension. AIDS Care. 2010;22:816-26.
6. Cocohoba J, Dong B. ARV medication errors: experience of a community based HIV specialty clinic and review of the literature. Hosp Pharm. 2007;42:720-8.
7. Edelstein H, Wilson M. Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital. J Acquir Immune Defic Syndr. 2001;28:496.
8. Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother. 2000;34:833-8.
9. Robinson CA, Cocohoba J, MacDougall C, et al. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc. 2007;47:613-5.
10. Hirsch JD, Gonzales M, Rosenquist A, et al. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17:213-23.
11. Hirsch JD, Rosenquist A, Best BM, et al. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15:32-41.
12. Rosenquist A, Best BM, Miller TA, et al. Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010;16:1142-6.
13. Inciardi JF, Leeds AL. Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus. Pharmacotherapy. 2005;25:790-6.
14. Fairley CK, Permana A, Read TR. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med. 2005;6:366-9.
15. Gross R, Yip B, Lo Re V 3rd, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194:1108-14.
16. Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4(4):187-91.
17. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1107-10.
18. Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5(5):109.
19. Department of Health & Human Services Public Service Task Force. Guidelines for the use of antiretroviral agents in HIV- 1-infected adults and adolescents. Accessed at www.aidsinfo. nih.gov/contentfiles/lvguidelines/ adultandadolescentgl.pdf, January 6, 2012.
20. Women's Interagency HIV Study. Definition of highly active antiretroviral therapy (HAART). Accessed at https://statepiaps. jhsph.edu/wihs/Invest-info/ Def-HAART-0609.pdf, January 6, 2012.
21. Multicenter AIDS Cohort Study. HAART definition. Accessed at www.statepi.jhsph.edu/macs/manuscript.html, January 6, 2012.
22. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-41.
23. Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223-31.
24. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-66.
25. Bangsberg DR, Porco TC, Kagay C, et al. Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004;190:162-5.
26. Kuhn C, Powell PH, Sterrett JJ. Elective course on medication therapy management services. Am J Pharm Educ. 2010;74(3):40.
27. Blake KB, Madhavan SS, Scott VG, et al. Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs. Res Social Adm Pharm. 2009;5:182-8.
28. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a communitybased medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133-47.
29. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based longterm medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23-31.
30. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
31. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacistprovided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15:18-31.
32. Llibre JM, Arribas JR, Domingo P, et al. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS. 2011;25:1683-90.
33. Stone VE, Jordan J, Tolson J, et al. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr. 2004;36:808-16.
34. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-16.
35. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565-74.
36. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-8.
37. McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 52:493-506.